HR3391Referred to Committee

End Price Gouging for Medications Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-14
Introduced
1
Cosponsors
HR
ⓘ
Type

Sponsor

Debbie Dingell
Debbie Dingell
Democrat · MI · Representative
Votes with party: 99.1% (542 recorded votes)

Full profile: /officials/D000624

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

1 cosponsor on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Subcommittee on Health.

2025-07-02

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The legislation would allow the federal government to investigate and penalize pharmaceutical companies that dramatically raise prices on existing medications without justification. It would give regulators tools to cap prices on drugs when they determine companies are unfairly exploiting patients and insurance companies, particularly for life-saving or essential medications. The law would affect drug manufacturers, patients paying for prescriptions, and insurance companies that cover medication costs.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.